SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-15-000034
Filing Date
2015-08-05
Accepted
2015-08-04 18:03:38
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prta2015q210-q.htm 10-Q 885932
2 EXHIBIT 31.1 prta2015q210-qxex311.htm EX-31.1 14360
3 EXHIBIT 31.2 prta2015q210-qxex312.htm EX-31.2 14425
4 EXHIBIT 32.1 prta2015q210-qxex321.htm EX-32.1 14598
  Complete submission text file 0001559053-15-000034.txt   3563947

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20150630.xml EX-101.INS 513216
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20150630.xsd EX-101.SCH 35366
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20150630_cal.xml EX-101.CAL 50374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20150630_def.xml EX-101.DEF 118206
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20150630_lab.xml EX-101.LAB 412900
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20150630_pre.xml EX-101.PRE 225539
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 151026828
SIC: 2834 Pharmaceutical Preparations